BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11121308)

  • 1. Structure and molecular mechanism of a functional form of pneumolysin: a cholesterol-dependent cytolysin from Streptococcus pneumoniae.
    Kelly SJ; Jedrzejas MJ
    J Struct Biol; 2000 Oct; 132(1):72-81. PubMed ID: 11121308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the structure and mechanism of a bacterial protein toxin by analytical ultracentrifugation and small-angle neutron scattering.
    Gilbert RJ; Heenan RK; Timmins PA; Gingles NA; Mitchell TJ; Rowe AJ; Rossjohn J; Parker MW; Andrew PW; Byron O
    J Mol Biol; 1999 Nov; 293(5):1145-60. PubMed ID: 10547292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of domain 4 of pneumolysin from Streptococcus pneumoniae in cytolytic activity as determined by truncated proteins.
    Baba H; Kawamura I; Kohda C; Nomura T; Ito Y; Kimoto T; Watanabe I; Ichiyama S; Mitsuyama M
    Biochem Biophys Res Commun; 2001 Feb; 281(1):37-44. PubMed ID: 11178957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular mechanism of pneumolysin, a virulence factor from Streptococcus pneumoniae.
    Rossjohn J; Gilbert RJ; Crane D; Morgan PJ; Mitchell TJ; Rowe AJ; Andrew PW; Paton JC; Tweten RK; Parker MW
    J Mol Biol; 1998 Nov; 284(2):449-61. PubMed ID: 9813129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallization and preliminary X-ray diffraction analysis of a functional form of pneumolysin, a virulence factor from Streptococcus pneumoniae.
    Kelly SJ; Jedrzejas MJ
    Acta Crystallogr D Biol Crystallogr; 2000 Nov; 56(Pt 11):1452-5. PubMed ID: 11053849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the solution properties and conformation of pneumolysin, the membrane-damaging toxin of Streptococcus pneumoniae.
    Morgan PJ; Varley PG; Rowe AJ; Andrew PW; Mitchell TJ
    Biochem J; 1993 Dec; 296 ( Pt 3)(Pt 3):671-4. PubMed ID: 8280065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based functional studies for the cellular recognition and cytolytic mechanism of pneumolysin from Streptococcus pneumoniae.
    Park SA; Park YS; Bong SM; Lee KS
    J Struct Biol; 2016 Feb; 193(2):132-40. PubMed ID: 26688057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cholesterol-dependent cytolysin pneumolysin from Streptococcus pneumoniae binds to lipid raft microdomains in human corneal epithelial cells.
    Taylor SD; Sanders ME; Tullos NA; Stray SJ; Norcross EW; McDaniel LS; Marquart ME
    PLoS One; 2013; 8(4):e61300. PubMed ID: 23577214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of Streptococcus pneumoniae pneumolysin provides key insights into early steps of pore formation.
    Lawrence SL; Feil SC; Morton CJ; Farrand AJ; Mulhern TD; Gorman MA; Wade KR; Tweten RK; Parker MW
    Sci Rep; 2015 Sep; 5():14352. PubMed ID: 26403197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cholesterol-dependent cytolysins pneumolysin and streptolysin O require binding to red blood cell glycans for hemolytic activity.
    Shewell LK; Harvey RM; Higgins MA; Day CJ; Hartley-Tassell LE; Chen AY; Gillen CM; James DB; Alonzo F; Torres VJ; Walker MJ; Paton AW; Paton JC; Jennings MP
    Proc Natl Acad Sci U S A; 2014 Dec; 111(49):E5312-20. PubMed ID: 25422425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the Pore-Forming Steps of Pneumolysin from Streptococcus pneumoniae.
    van Pee K; Mulvihill E; Müller DJ; Yildiz Ö
    Nano Lett; 2016 Dec; 16(12):7915-7924. PubMed ID: 27796097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cholesterol-dependent cytolysin family of gram-positive bacterial toxins.
    Heuck AP; Moe PC; Johnson BB
    Subcell Biochem; 2010; 51():551-77. PubMed ID: 20213558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How cholesterol-dependent cytolysins bite holes into membranes.
    Walz T
    Mol Cell; 2005 May; 18(4):393-4. PubMed ID: 15893721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae.
    Gilbert RJ; Jiménez JL; Chen S; Tickle IJ; Rossjohn J; Parker M; Andrew PW; Saibil HR
    Cell; 1999 May; 97(5):647-55. PubMed ID: 10367893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid microtubule bundling and stabilization by the Streptococcus pneumoniae neurotoxin pneumolysin in a cholesterol-dependent, non-lytic and Src-kinase dependent manner inhibits intracellular trafficking.
    Iliev AI; Djannatian JR; Opazo F; Gerber J; Nau R; Mitchell TJ; Wouters FS
    Mol Microbiol; 2009 Jan; 71(2):461-77. PubMed ID: 19040644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of pneumolysin from Streptococcus pneumoniae, interacting with carbohydrate moiety and cholesterol as a component of cell membrane.
    Lim JE; Park SA; Bong SM; Chi YM; Lee KS
    Biochem Biophys Res Commun; 2013 Jan; 430(2):659-63. PubMed ID: 23211600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligomerisation of pneumolysin on cholesterol crystals: similarities to the behaviour of polyene antibiotics.
    Sonnen AF; Rowe AJ; Andrew PW; Gilbert RJ
    Toxicon; 2008 Jun; 51(8):1554-9. PubMed ID: 18501941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cholesterol-dependent Cytolysin Membrane-binding Interface Discriminates Lipid Environments of Cholesterol to Support β-Barrel Pore Insertion.
    Farrand AJ; Hotze EM; Sato TK; Wade KR; Wimley WC; Johnson AE; Tweten RK
    J Biol Chem; 2015 Jul; 290(29):17733-17744. PubMed ID: 26032415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of Recognition Sites of Monoclonal Antibodies Responsible for the Inhibition of Pneumolysin Functional Activity.
    Kucinskaite-Kodze I; Simanavicius M; Dapkunas J; Pleckaityte M; Zvirbliene A
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32650398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ca²⁺-dependent repair of pneumolysin pores: A new paradigm for host cellular defense against bacterial pore-forming toxins.
    Wolfmeier H; Schoenauer R; Atanassoff AP; Neill DR; Kadioglu A; Draeger A; Babiychuk EB
    Biochim Biophys Acta; 2015 Sep; 1853(9):2045-54. PubMed ID: 25219550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.